EZH2 and myeloid neoplasm: In addition, a previous study that analyzed PRC2 mutations in myeloid malignancies reported that samples with inactivation and/or hypomorphic mutations in EZH2 gene frequently carried concomitant mutations in the Tet2, Asxl1, and Runx1 genes17.